DyAnsys, Inc.   Report issue

For profit
Founded: Geneva Switzerland (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2019
NCT03829774
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

DyAnsys, Inc.